Page 32 - GALENIKA MEDICAL JOURNAL
P. 32

18.  Kalluru R, Gadde S, Chikatimalla R, Dasaradhan T, Koneti J, Cherukuri   25.  Vera A, Cecconi A, Martínez-Vives P, Olivera MJ, Hernández S, López-
             SP. Cirrhotic Cardiomyopathy: The Interplay Between Liver and Heart.   Melgar B, et al. Electrocardiogram and CMR to differentiate tachycardia-
             Cureus. 2022 Aug 13;14(8):e27969.                  induced cardiomyopathy from dilated cardiomyopathy in patients
                                                                admitted for heart failure. Heart Vessels. 2022 Nov;37(11):1850-8.
          19.  Rodriguez Ziccardi M, Siddique MS. Peripartum Cardiomyopathy.
             2022 Jul 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls   26.  Stanford S, Roy A, Rea C, Harris B, Ashton A, Mangles S, et al. Pilot
             Publishing; 2022 Jan–.                             study to evaluate hypercoagulation and inflammation using rotational
                                                                thromboelastometry and calprotectin in COVID-19 patients. PLoS One.
          20.  Shaaban A, Gangwani MK, Pendela VS, Vindhyal MR. Alcoholic   2023 Jan 6;18(1):e0269738.
             Cardiomyopathy. 2022 Aug 8. In: StatPearls [Internet]. Treasure Island
             (FL): StatPearls Publishing; 2022 Jan–.         27.  Shah RM, Shah M, Shah S, Li A, Jauhar S. Takotsubo Syndrome and
                                                                COVID-19: Associations and Implications. Curr Probl Cardiol. 2021
          21.  Dillmann WH. Diabetic Cardiomyopathy. Circ Res. 2019 Apr   Mar;46(3):100763.
             12;124(8):1160-2.
          22.  Huizar JF, Ellenbogen KA, Tan AY, Kaszala K. Arrhythmia-Induced
             Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019
             May 14;73(18):2328-44.                             Konflikt interesa: Nema
          23.  Báez Cabanillas MV, Colque R, Tibaldi MÁ, Kaplinsky E, Perrone S,   Primljeno: 15. 01. 2023.
             Barbagelata A. Emerging concepts in heart failure management and
             treatment: focus on tachycardia-induced cardiomyopathy. Drugs   Prihvaćeno: 06. 02. 2023.
             Context. 2023 Jan 4;12:2022-8-4.                   Onlajn: 01. 03. 2023.
          24.  Orlov OS, Asfour A, Bogdanova AA, Shchekochikhin DY, Akselrod AS,
             Nesterov AP, et al. Predictors of tachycardia-induced cardiomyopathy in
             patients with first-time decompensation of chro-nic heart failure with
             reduced left ventricular ejection fraction of nonischemic etiology and
             persistent atrial tachyarrhythmia. Kardiologiia. 2022 Nov 30;62(11):56-
             62.































































          30     DOI: 10.5937/Galmed2305023D
   27   28   29   30   31   32   33   34   35   36   37